152 related articles for article (PubMed ID: 9403084)
1. [What is new? Therapy with lipid lowering agents].
Internist (Berl); 1997 Nov; 38(11 Suppl Therapie):1-8. PubMed ID: 9403084
[No Abstract] [Full Text] [Related]
2. Atorvastatin--a new lipid-lowering drug.
Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
[No Abstract] [Full Text] [Related]
3. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
[No Abstract] [Full Text] [Related]
4. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
[No Abstract] [Full Text] [Related]
5. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
Liguori E; Sarcinella R
Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
[No Abstract] [Full Text] [Related]
6. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
[No Abstract] [Full Text] [Related]
7. [Effective cholesterol and triglyceride lowering with atorvastatin].
Internist (Berl); 1996 Aug; 37(8 Suppl Effektive):1-8. PubMed ID: 9404527
[No Abstract] [Full Text] [Related]
8. Liptruzet: a combination of ezetimibe and atorvastatin.
Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
[No Abstract] [Full Text] [Related]
9. Reversal of atherosclerosis with aggressive lipid lowering.
Farmer JA
Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
[No Abstract] [Full Text] [Related]
10. Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia.
Tanaka N; Momiyama Y; Ohmori R; Yonemura A; Ayaori M; Ogura M; Sawada S; Kusuhara M; Nakamura H; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):e129-30. PubMed ID: 16857954
[No Abstract] [Full Text] [Related]
11. Atorvastatin: a new agent for hyperlipidemia.
Kupecz D
Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
[No Abstract] [Full Text] [Related]
12. Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia.
Del Ben M; Burattin M; Arca M; Ceci F; Violi F; Angelico F
Am J Med; 2004 Nov; 117(10):803-4. PubMed ID: 15541334
[No Abstract] [Full Text] [Related]
13. Atorvastatin.
Hyatt PJ
Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
[No Abstract] [Full Text] [Related]
14. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
Aalbers J
Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
[No Abstract] [Full Text] [Related]
15. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Phillips PS
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
[No Abstract] [Full Text] [Related]
16. Atorvastatin: in the management of hyperlipidaemia.
Ray SK; Rege NN
J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
[No Abstract] [Full Text] [Related]
17. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
Nissen S
MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143
[No Abstract] [Full Text] [Related]
18. Statins revisited.
Harv Heart Lett; 1998 May; 8(9):1-3. PubMed ID: 9579111
[No Abstract] [Full Text] [Related]
19. Statin face-off. Surprises from the first head-to-head comparison.
Gupta S
Time; 2003 Nov; 162(21):83. PubMed ID: 14666603
[No Abstract] [Full Text] [Related]
20. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
März W
MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
